Infection prevention leadership Cantel Medical, now part of STERIS, operates in infection prevention within the medical device space, presenting a long-term opportunity to cross-sell enhanced sterilization, tracking, and endoscopy reprocessing solutions to healthcare providers seeking integrated infection control portfolios.

Endoscope tracking expertise Historical launches of the ENDORA Endoscope Tracking System demonstrate a strengths-based capabilities in electronic documentation and workflow tracking; a selling point for hospitals aiming to improve compliance, traceability, and high-level disinfection validation across reprocessing cycles.

Growth through acquisition As a division aligned with a larger STERIS ecosystem, there are opportunities to position Cantel offerings alongside broader sterilization and equipment management solutions, leveraging cross-sell potential to existing STERIS customers and channels.

Mid-market scale focus With 201-500 employees and revenues in the mid-range, target mid to large healthcare facilities and regional health systems that require scalable infection prevention products and services, while highlighting cost efficiency and service reliability.

Technology and data Leveraging tech stack capabilities such as analytics, content management, and secure documentation workflows suggests upsell opportunities for analytics dashboards, regulatory reporting, and enhanced IT-enabled product tracking for endoscopy and reprocessing programs.